Recent Advancements in Gremlin-1: Breast cancer

被引：1

作者：

Inam, Nimrah ^{[1
]}

Hameed, Ayesha ^{[2
]}

Vohra, Lubna ^{[3
]}

Zeeshan, Sana ^{[3
]}

机构：

[1] Aga Khan Univ Hosp, Dept Paediat, Karachi, Pakistan

[2] Jinnah Med & Dent Coll, Karachi, Pakistan

[3] Aga Khan Univ Hosp, Dept Breast Surg, Karachi, Pakistan

来源：

JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION | 2023年 / 73卷 / 02期

关键词：

Bone Morphogenetic; Carcinogenesis; Organogenesis; Colorectal Neoplasms; breast cancers; stem cells; TARGETED THERAPIES; CELLS; METASTASIS; GROWTH;

D O I：

10.47391/JPMA.AKUS-25

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

One of the bone's morphogenic protein (BMP) antagonists, Gremlin-1 or GREM-1, can bind directly to BMPs. GREM-1 can act in either BMP-dependent or independent pathways, according to research. It reinforces organogenesis, tissue differentiation, and organ fibrosis. Recent research from numerous studies has demonstrated the significance of GREM-1 in the initiation, progression, and even metastasis of different cancers, including breast, cervical, gastric, and colorectal cancers. This review highlights the function of GREM-1 in the development of breast cancer and its effect on the cellular procedures and signalling pathways involved in carcinogenesis.

引用

页码：S155 / S159

页数：5

共 50 条

[41] Gremlin-1 Induces BMP-Independent Tumor Cell Proliferation, Migration, and Invasion
Kim, Minsoo
Yoon, Soomin
Lee, Sukmook
Ha, Seon Ah
Kim, Hyun Kee
Kim, Jin Woo
Chung, Junho
PLOS ONE, 2012, 7 (04):
[42] Intrinsic BMP Antagonist Gremlin-1 as a Novel Circulating Marker in Pulmonary Arterial Hypertension
Jasmin Wellbrock
Lars Harbaum
Hauke Stamm
Jan K. Hennigs
Björn Schulz
Hans Klose
Carsten Bokemeyer
Walter Fiedler
Nicole Lüneburg
Lung, 2015, 193 : 567 - 570
[43] Enrichment map profiling of the cancer invasion front suggests regulation of colorectal cancer progression by the bone morphogenetic protein antagonist, gremlin-1
Karagiannis, George S.
Berk, Aaron
Dimitromanolakis, Apostolos
Diamandis, Eleftherios P.
MOLECULAR ONCOLOGY, 2013, 7 (04): : 826 - 839
[44] Gremlin-1 in pregnancy and postpartum: health risk monitoring of women with gestational diabetes mellitus
Kawada, Tomoyuki
ACTA DIABETOLOGICA, 2024, 61 (01) : 135 - 136
[45] Gremlin-1 in pregnancy and postpartum: health risk monitoring of women with gestational diabetes mellitus
Tomoyuki Kawada
Acta Diabetologica, 2024, 61 : 135 - 136
[46] Gremlin-1 Promotes Colorectal Cancer Cell Metastasis by Activating ATF6 and Inhibiting ATF4 Pathways
Li, Ruohan
Zhou, Huaixiang
Li, Mingzhe
Mai, Qiuyan
Fu, Zhang
Jiang, Youheng
Li, Changxue
Gao, Yunfei
Fan, Yunping
Wu, Kaiming
Da Costa, Clive
Sheng, Xia
He, Yulong
Li, Ningning
CELLS, 2022, 11 (14)
[47] Intrinsic BMP Antagonist Gremlin-1 as a Novel Circulating Marker in Pulmonary Arterial Hypertension
Wellbrock, Jasmin
Harbaum, Lars
Stamm, Hauke
Hennigs, Jan K.
Schulz, Bjoern
Klose, Hans
Bokemeyer, Carsten
Fiedler, Walter
Lueneburg, Nicole
LUNG, 2015, 193 (04) : 567 - 570
[48] Epigenetic Modulation of Gremlin-1/NOTCH Pathway in Experimental Crescentic Immune-Mediated Glomerulonephritis
Tejedor-Santamaria, Lucia
Morgado-Pascual, Jose Luis
Marquez-Exposito, Laura
Suarez-Alvarez, Beatriz
Rodrigues-Diez, Raul R.
Tejera-Munoz, Antonio
Marchant, Vanessa
Mezzano, Sergio
Lopez-Larrea, Carlos
Sola, Anna
Fernandez-Juarez, Gema Maria
Ortiz, Alberto
Rayego-Mateos, Sandra
Ruiz-Ortega, Marta
PHARMACEUTICALS, 2022, 15 (02)
[49] Gremlin-1 inhibits macrophage migration inhibitory factor-dependent monocyte function and survival
Mueller, Iris I.
Chatterjee, Madhumita
Schneider, Martina
Borst, Oliver
Seizer, Peter
Schoenberger, Tanja
Vogel, Sebastian
Mueller, Karin A. L.
Geisler, Tobias
Lang, Florian
Langer, Harald
Gawaz, Meinrad
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 176 (03) : 923 - 929
[50] Editorial: Recent advancements in neoadjuvant chemotherapy for specific breast cancer subtypes
Adham, Sirin A.
Szewczuk, Myron R.
Mraiche, Fatima
Petricoin, Emanuel
FRONTIERS IN ONCOLOGY, 2022, 12

← 1 2 3 4 5 →